RJR-2429
RJR-2429' is a chemical compound that acts as a nicotinic acetylcholine receptor (nAChR) agonist. It is primarily used in scientific research to study the effects of nAChR activation.
Chemical Structure and Properties[edit | edit source]
RJR-2429 is a synthetic compound with a complex chemical structure. It is classified as a nicotine analog due to its ability to bind to and activate nicotinic acetylcholine receptors. The molecular formula of RJR-2429 is C 10H 14N 2, and it has a molecular weight of 162.23 g/mol.
Mechanism of Action[edit | edit source]
RJR-2429 functions by binding to the nicotinic acetylcholine receptors, which are a type of ligand-gated ion channel found in the central nervous system and peripheral nervous system. Upon binding, it mimics the action of the neurotransmitter acetylcholine, leading to the opening of the ion channel and subsequent influx of sodium ions. This results in the depolarization of the neuron and the propagation of an action potential.
Research Applications[edit | edit source]
RJR-2429 is used extensively in neuroscience research to investigate the role of nicotinic acetylcholine receptors in various physiological and pathological processes. It has been studied in the context of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease, as well as in addiction research to understand the mechanisms underlying nicotine addiction.
Pharmacological Effects[edit | edit source]
The activation of nicotinic acetylcholine receptors by RJR-2429 can lead to a variety of pharmacological effects, including enhanced cognitive function, increased alertness, and improved memory. These effects are similar to those observed with nicotine, but RJR-2429 is often preferred in research due to its specificity and potency.
Safety and Toxicity[edit | edit source]
As with many research chemicals, the safety and toxicity profile of RJR-2429 is not fully understood. It is typically handled with caution in laboratory settings, and its use is restricted to controlled environments.
See Also[edit | edit source]
- Nicotinic acetylcholine receptor
- Nicotine
- Acetylcholine
- Neurotransmitter
- Ligand-gated ion channel
- Neurodegenerative disease
- Addiction
References[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
